Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $551.02 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $334.49 | 19 | $0 (2024) |
| Grifols USA, LLC | $56.86 | 3 | $0 (2022) |
| Novo Nordisk Inc | $39.97 | 2 | $0 (2022) |
| Lilly USA, LLC | $37.53 | 2 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $31.86 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $31.78 | 2 | $0 (2022) |
| Indivior Inc. | $18.53 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68.01 | 3 | ABBVIE INC. ($68.01) |
| 2022 | $483.01 | 28 | ABBVIE INC. ($266.48) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Pulmonology | ||||||
| 10/12/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 10/04/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Central Nervous System | ||||||
| 09/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Pulmonology | ||||||
| 07/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: BH | ||||||
| 07/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $65.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: VIROLOGY | ||||||
| 06/13/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Pulmonology | ||||||
| 06/13/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 330 | 967 | $144,785 | $67,134 |
| 2022 | 4 | 56 | 84 | $15,678 | $6,922 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 73 | 444 | $71,040 | $35,073 | 49.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 63 | 242 | $30,285 | $11,192 | 37.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 52 | 91 | $14,560 | $7,572 | 52.0% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 34 | 54 | $12,150 | $6,381 | 52.5% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 35 | 35 | $7,875 | $2,756 | 35.0% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 41 | $3,485 | $1,803 | 51.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 31 | $2,480 | $1,187 | 47.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 18 | 18 | $2,250 | $844.18 | 37.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 11 | $660.00 | $325.93 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 32 | $6,112 | $2,540 | 41.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 18 | $4,626 | $1,916 | 41.4% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 11 | 18 | $2,870 | $1,515 | 52.8% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 12 | 16 | $2,070 | $951.04 | 45.9% |
About Sarah Chandler, DNP
Sarah Chandler, DNP is a Gerontology healthcare provider based in Ontario, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720144793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Chandler, DNP has received a total of $551.02 in payments from pharmaceutical and medical device companies, with $68.01 received in 2024. These payments were reported across 31 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($551.02).
As a Medicare-enrolled provider, Chandler has provided services to 386 Medicare beneficiaries, totaling 1,051 services with total Medicare billing of $74,056. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Other Specialties Registered Nurse, Critical Care Medicine
- Location Ontario, OR
- Active Since 12/27/2006
- Last Updated 01/15/2025
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1720144793
Products in Payments
- UBRELVY (Drug) $139.79
- VRAYLAR (Drug) $135.15
- Prolastin-C Liquid (Biological) $56.86
- QULIPTA (Drug) $47.19
- AJOVY (Biological) $31.86
- FARXIGA (Drug) $31.78
- Rybelsus (Drug) $23.03
- EMGALITY (Drug) $19.76
- PERSERIS (Drug) $18.53
- TRULICITY (Drug) $17.77
- Ozempic (Drug) $16.94
- MAVYRET (Drug) $12.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.